388 related articles for article (PubMed ID: 20551689)
1. Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies.
Kokoulina P; Rohn TT
Neurodegener Dis; 2010; 7(4):243-50. PubMed ID: 20551689
[TBL] [Abstract][Full Text] [Related]
2. Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease.
Rohn TT; Kokoulina P
Int J Physiol Pathophysiol Pharmacol; 2009 Jan; 1(1):25-32. PubMed ID: 20411029
[TBL] [Abstract][Full Text] [Related]
3. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
4. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
5. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
6. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
[TBL] [Abstract][Full Text] [Related]
7. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
Nakashima-Yasuda H; Uryu K; Robinson J; Xie SX; Hurtig H; Duda JE; Arnold SE; Siderowf A; Grossman M; Leverenz JB; Woltjer R; Lopez OL; Hamilton R; Tsuang DW; Galasko D; Masliah E; Kaye J; Clark CM; Montine TJ; Lee VM; Trojanowski JQ
Acta Neuropathol; 2007 Sep; 114(3):221-9. PubMed ID: 17653732
[TBL] [Abstract][Full Text] [Related]
8. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
[TBL] [Abstract][Full Text] [Related]
9. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
[TBL] [Abstract][Full Text] [Related]
10. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Grochowska MM; Carreras Mascaro A; Boumeester V; Natale D; Breedveld GJ; Geut H; van Cappellen WA; Boon AJW; Kievit AJA; Sammler E; ; Parchi P; Cortelli P; Alessi DR; van de Berg WDJ; Bonifati V; Mandemakers W
Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Kawamoto Y; Ito H; Ayaki T; Takahashi R
Brain Res; 2014 Jul; 1571():39-48. PubMed ID: 24835407
[TBL] [Abstract][Full Text] [Related]
12. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
13. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains.
Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A
Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884
[TBL] [Abstract][Full Text] [Related]
14. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
[TBL] [Abstract][Full Text] [Related]
15. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.
Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U
Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389
[TBL] [Abstract][Full Text] [Related]
16. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
17. Involvement of autophagic protein DEF8 in Lewy bodies.
Tanaka MT; Miki Y; Bettencourt C; Ozaki T; Tanji K; Mori F; Kakita A; Wakabayashi K
Biochem Biophys Res Commun; 2022 Oct; 623():170-175. PubMed ID: 35921708
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.
Francis PT
J Neurol; 2009 Aug; 256 Suppl 3():280-5. PubMed ID: 19711117
[TBL] [Abstract][Full Text] [Related]
19. Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson's Disease Patients and Is Present within Lewy Bodies.
Chatterjee M; van Steenoven I; Huisman E; Oosterveld L; Berendse H; van der Flier WM; Del Campo M; Lemstra AW; van de Berg WDJ; Teunissen CE
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32806791
[TBL] [Abstract][Full Text] [Related]
20. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
